DeepMed Research

Medical University of Silesia

🇵🇱Poland

Country: 🇵🇱Poland

Ownership: Private

Established: 1948-03-20

Employees: -

Market Cap: -

Website: http://www.smk.sum.edu.pl

Clinical Trials

SPI-directed Analgesia for Vitreoretinal Surgeries

Not Applicable

Completed

Conditions: Postoperative Pain
Postoperative Nausea and Vomiting
Vitreoretinal Surgeries

Interventions: Drug: Metamizol
Drug: Acetaminophen
Drug: 0,5 % bupivacaine with of 2% lidocaine
Drug: Proxymetacaine

First Posted Date: 2016-11-25

Last Posted Date: 2018-01-23

Lead Sponsor: Medical University of Silesia

Target Recruit Count: 176

Registration Number: NCT02973581

Locations: 🇵🇱
Medical University of Silesia, Sosnowiec, Silesia, Poland

SPI-directed Analgesia for Lumbar Discectomy

Not Applicable

Completed

Conditions: Lumbar Disc Disease

Interventions: Drug: Metamizol
Drug: Tramadol
Other: control group
Drug: Bupivacaine
Drug: Ropivacaine

First Posted Date: 2016-11-23

Last Posted Date: 2019-04-16

Lead Sponsor: Medical University of Silesia

Target Recruit Count: 132

Registration Number: NCT02971540

Locations: 🇵🇱
Medical University of Silesia, Sosnowiec, Silesia, Poland

Collagen Matrix With Tunnel Technique Compared to CTG for the Treatment of Periodontal Recessions

Not Applicable

Completed

Conditions: Gingival Recession

First Posted Date: 2015-12-16

Last Posted Date: 2015-12-18

Lead Sponsor: Medical University of Silesia

Target Recruit Count: 28

Registration Number: NCT02632240

Locations: 🇵🇱
Department of Periodontal and Oral Mucosa Diseases, Zabrze, Poland

Grass Pollen Subcutaneous Immunotherapy in Elderly Patients

Phase 4

Completed

Conditions: Allergy

Interventions: Drug: Purethal
Drug: Purethal -placebo

First Posted Date: 2015-05-12

Last Posted Date: 2015-05-12

Lead Sponsor: Medical University of Silesia

Target Recruit Count: 120

Registration Number: NCT02440243

Myorelaxant Effect of Bee Venom(BV) Topical Skin Application in Patients With RDC/TMD Ia and Ib

Not Applicable

Completed

Conditions: Other Disorders of Muscle in Diseases Classified Elsewhere

Interventions: Dietary Supplement: Bee Venom Ointment
Other: Vaseline Ointment

First Posted Date: 2014-04-02

Last Posted Date: 2017-12-11

Lead Sponsor: Medical University of Silesia

Target Recruit Count: 79

Registration Number: NCT02101632

Locations: 🇵🇱
Department of TMD and Orthodontics Silesian Medical University, Zabrze, Poland

Remote Ischemic Preconditioning of Human Myocardium

Phase 2

Completed

Conditions: Coronary Artery Bypass Graft Triple Vessel
Apoptotic DNA Damage

Interventions: Procedure: Placebo
Procedure: Remote ischemic preconditioning

First Posted Date: 2013-11-26

Last Posted Date: 2018-01-12

Lead Sponsor: Medical University of Silesia

Target Recruit Count: 134

Registration Number: NCT01994707

Locations: 🇵🇱
Medical University of Silesia, Katowice, Poland

Gene Expression in Patients With Epiretinal Membranes

Conditions: Proliferative Diabetic Retinopathy

First Posted Date: 2013-09-19

Last Posted Date: 2013-09-19

Lead Sponsor: Medical University of Silesia

Registration Number: NCT01946451

Locations: 🇵🇱
Medical University of Silesia, Katowice, Poland

Clinical Effects of Eptifibatide Administration in High Risk Patients Presenting With Non-ST Segment Elevation Acute Coronary Syndrome (NSTE-ACS) Requiring Urgent Coronary Artery Bypass Graft Surgery in Short- and Long-Term Follow-up

Phase 4

Completed

Conditions: Non ST Elevation Myocardial Infarction

Interventions: Drug: Placebo
Drug: Eptifibatide

First Posted Date: 2013-05-27

Last Posted Date: 2013-10-31

Lead Sponsor: Medical University of Silesia

Target Recruit Count: 140

Registration Number: NCT01863134

Locations: 🇵🇱
Center for Cardiovascular Research and Development, American Heart of Poland, Katowice, Poland
🇵🇱
Department of Internal Medicine and Clinical Pharmacology, Katowice, Poland
🇵🇱
Division of Molecular Biology and Clinical Genetics, Jagiellonian University Medical College, Krakow, Poland

and more 3 locations

Valsartan to Prevent Left Ventricle Remodeling in Pacemaker Patients

Phase 4

Terminated

Conditions: First Time Dual Chamber Pacemaker Implantation

Interventions: Drug: placebo/valsartan

First Posted Date: 2013-03-06

Last Posted Date: 2023-04-12

Lead Sponsor: Medical University of Silesia

Target Recruit Count: 88

Registration Number: NCT01805804

Locations: 🇵🇱
II Dept. of Cardiology in Zabrze Medical University of Silesia, Zabrze, Upper Silesia, Poland

Intracardiac CD133+ Cells in Patients With No-option Resistant Angina

Phase 2

Completed

Conditions: Stable Angina

Interventions: Biological: Placebo
Biological: intramyocardial injection (electromechanical mapping based)

First Posted Date: 2012-08-08

Last Posted Date: 2017-09-28

Lead Sponsor: Medical University of Silesia

Target Recruit Count: 31

Registration Number: NCT01660581

Locations: 🇵🇱
Samodzielny Publiczny Szpital Kliniczny nr 7 Śląskiego Uniwersytetu Medycznego w Katowicach Górnośląskie Centrum Medyczne im. prof. Leszka Gieca, Katowice-Ochojec, Silesian, Poland

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy